Posts by vgn1
SARS-CoV-2 Lambda Variant: The New Kid on the Block
SARS-CoV-2 Lambda Variant: The New Kid on the Block July 19, 2021 The COVID-19 pandemic has been marked by the ongoing emergence of new genetic variants. Although SARS-CoV-2 is an RNA virus, its genome is relative stable, thanks to a proofreading polymerase. However, in a situation with extensive viral transmission globally, the evolution of SARS-CoV-2…
Read MoreGlobal Virus Network (GVN) Adds Senegal’s IRESSEF As Newest Member to Mitigate Viral Threats
Baltimore, Maryland, USA, July 15, 2021: The Global Virus Network (GVN), representing 63 Centers of Excellence and 11 Affiliates in 35 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation , or the IRESSEF, announced the addition of…
Read MoreDoes COVID-19 Curb or Promote the Progression of Cancer?
Does COVID-19 Curb or Promote the Progression of Cancer? July 2, 2021 One of the many questions about the long-term implications of COVID-19 is whether there might be some positive or negative consequences on cancer. The inflammatory milieu elicited by infection with SARS-CoV-2 might elicit pro-cancer effects as well as COVID-related immune-deficiency or increase DNA…
Read MoreA Media Briefing Addressing the Exploding International COVID-19 Crisis: Global Virus Network – Ideas For a Global Vaccination Strategy
June 30, 2021 Drs. Robert Gallo, Christian Bréchot, Sharon Lewin, and Amadou Sall Global Vaccination Vaccination is one of the most effective control measures for human infectious diseases. COVID-19 vaccines, particularly mRNA vaccines, have been very effective, including against the current SARS-CoV-2 variants. Thus, successful vaccination has resulted in mitigating SARS-CoV-2 infection in countries, such…
Read MoreGlobal Virus Network (GVN) Adds Gilead Sciences to GVN Healthcare & Pharma Centers of Excellence Coalition
The Partnership Focuses on Stimulating Collaborations and Training the Next Generation of Virus Researchers to Prepare for and Mitigate Future Global Threats Baltimore, Maryland, USA, June 30, 2021: The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research…
Read MoreImpact of the Delta Variant on Transmission, Vaccine, and Treatment Efficacy
Impact of the Delta Variant on Transmission, Vaccine, and Treatment Efficacy June 21, 2021 One of the consequences of unchecked SARS-CoV-2 infections is the generation of mutations that have the potential to increase infectivity and transmissibility, confer a degree of resistance to vaccines, neutralizing antibodies, and monoclonal antibody therapy, and in some cases generate false…
Read MoreOld vaccines for new pandemics (Ep 66) – Big Biology Podcast featuring Dr. Gallo and Dr. Chumakov – GVN
Celdara Medical and Global Virus Network Announce Collaboration to Advance Infectious Disease and Viral Infection Research and Development
The partnership will initially focus on SARS-CoV-2 and future pandemic threats. BALTIMORE, MD and CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, June 2, 2021 — Celdara Medical, LLC (Celdara), an experienced biopharma developer focused on launching promising products to the patients who need them the most, today announced a new strategic collaboration with the…
Read MoreVaccine Priorities: Children or Underserved Populations?
Vaccine Priorities: Children or Underserved Populations? May 24, 2021 In the setting of still somewhat limited vaccine supplies and deliveries, a current question is what the most effective priority is among those who are still not vaccinated. What will have the most effective dampening effect on the pandemic? There are several considerations. To what extent…
Read MoreGlobal Virus Network Analysis Suggests Measles, Polio and Tuberculosis Vaccines May Boost Immunity to Coronavirus
Innate Immunity Created by Live Attenuated Vaccines Like Measles and Polio May Provide Some Protection Against Future Pandemics – Idea Needs To Be Tested, Scientists Say BALTIMORE, MD, May 18, 2021: Members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in…
Read More